Financial Research Support  Financial Research Support
 Publications - Medical & Surgical - Part I (Internal Medicine Department)  Publications - Medical & Surgical - Part I (Internal Medicine Department)
 Publications - Medical & Surgical - Part II (Other Departments)  Publications - Medical & Surgical - Part II (Other Departments)
 Publications - Hospital Based Departments  Publications - Hospital Based Departments
 Publications - Health and Health Care Research  Publications - Health and Health Care Research
 Research Summaries - Medical & Surgical - Part I (Internal Medicine Dept.)  Research Summaries - Medical & Surgical - Part I (Internal Medicine Dept.)
 Research Summaries - Medical & Surgical - Part II (Other Departments)  Research Summaries - Medical & Surgical - Part II (Other Departments)
 Research Summaries - Medical & Surgical - Part III (Other Departments)  Research Summaries - Medical & Surgical - Part III (Other Departments)
 Research Summaries - Hospital Based Departments  Research Summaries - Hospital Based Departments
 Research Summaries - Health and Health Care Research  Research Summaries - Health and Health Care Research



Publications - Medical & Surgical - Part I (Internal Medicine Department)

Allergy & Immunology

  1. Nageotte CG. (2007) "Reply." J Allergy Clin Immunol; 119(3):758-759

Book Chapters:

  1. Morman S, Zoratti EM. Environmental Control in the Management of Allergic Respiratory Disorders in "Allergic Diseases: Diagnosis and Treatment". Third edition.  ( J Anderson and P Lieberman, Eds)  Humana Press, Totowa NJ, 2007.
Cardiology/Cardiovascular Research Top
  1. Abdel-Larig A, Tleyjeh IM, Perin E, Hornung C, Montori VM, Zuba-Surma E, Al-Mallah M, Bolli R, Dawn B. (2007) "Bone marrow stem cells in the treatment of ischemic cardiomyopathy:  A systematic review and meta analysis."  Arch Intern Med;167(10):989-997.
  2. Alesh I, Kayali F, Stein PD. (2007) "Catheter-directed thrombolysis (intra-thrombus injection) in treatment of deep venous thrombosis:  A systematic review."  Catheter Cardiovasc Interv; 70:143-148.
  3. Alexander KP, Newby L, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM. (2007) " Acute coronary care in the Elderly, non-ST segment elevation acute coronary syndromes - A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology."  Circulation; 115:2549-2569.
  4. Al-Mallah M, Bazari RN, Jankowski M and Hudson MP. (2007) "Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes." J Thromb Thrombolysis; 23(1):51-5. 
  5. Al-Mallah MH, Bazari RN and Khanal S. (2007) "Delay in invasive risk stratification of women with acute coronary syndrome is associated with worse outcomes." J Thromb Thrombolysis 23(1):35-9.
  6. Ananthasubramaniam K and Jaffery Z. (2007) "Postoperative right atrial compression by extracardiac hematoma: transesophageal echocardiographic diagnosis in the critically ill patient." Echocardiography 24(6): 661-3.
  7. Arida M, Garcia-Sayam E, Al-Mallah M, Assal C, Tapia Zegara C, Czerska B (2007) "What is the prognostic value of a normal adenosine myocardial perfusion imaging in cardiac transplant patients?"  J Heart and Lung Transplantation; 26(2): S238-S238.
  8. Brawner CA, Vanzant MA, Ehrman JK, Foster C, Porcari JP, Kelso AJ, Keteyian SJ. (2007) "Guiding exercise using the talk test among patients with coronary artery disease."  J Cardiopulm Rehabil; 26(2): 72-75.
  9. Brown PP, Houser F, Kugelmass AD, Anderson AL, Tarkington LG, Simon AW, Culler SD. (2007) "Performance improvement:  cardiovascular centers of excellence program:  A system approach for improving the care and outcomes of cardiovascular patients at HCA hospitals."  J on Quality and Patient Safety; 11:647-659.
  10. Butter C, Wellnhofer E, Schlegl M, Winbeck G, Fleck E, Sabbah HN. (2007) "Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption."  J Cardiac Failure; 13:137-142.
  11. Dudar BM, Kim HE. (2007) "Massive air embolus treated with rheolytic thrombectomy." J Invasive Cardiol; 19:E182-E184.
  12. Granger CB, Henry TD, Bates WER, Cercek B, Weaver WD, Williams DO. (2007) "Development of systems of care for ST-elevation myocardial infarction patients." Circulation; 116:e55-e59.
  13. Greenbaum AB, Ohman EM, Gibson CM, Borzak S, Stebbins AL, Lu M, Le May MR, Stankowski JE, Emanuelsson H and Weaver WD (2007) "Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial." Am Heart J; 154(4): 702-9.
  14. Gross BW, Dauterman KW, Moran MG, Kotler TS, Schnugg SJ, Rostykus PS, Ross AM, Weaver WD. (2007) "A regional approach to shorten time to infarct artery patency in patients with ST segment elevation myocardial infarction."  Am J Card; 99:1360-1363.
  15. Guevara R, Aguinaga-Meza M, Hazin MI, Hazin R and McCord J.  (2007) "Takotsubo cardiomyopathy complicated with acute pericarditis and cardiogenic shock." J Natl Med Assoc; 99(3): 281-3. 
  16. Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC, Mika Y, Rousso B, Burkhoff D, Ben-Haim S and Sabbah HN. (2007) "Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure." J Am Coll Cardiol; 49(21): 2120-8. 
  17. Imai M, Rastogi S, Sharma N, Chandler MP, Sharov VG, Blackburn B, Belardinelli L, Stanley WC and Sabbah HN. (2007) "CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure." Cardiovasc Drugs Ther; 21(1): 9-15.
  18. Jaffery Z and Ananthasubramaniam K. (2007) "An unusual echocardiographic appearance of complications related to infective endocarditis." J Ultrasound Med; 26(2): 279-80.
  19. Jaffery Z and Ananthasubramaniam K. (2007) "Isolated left pulmonary artery stenosis due to extrinsic compression by intra thoracic tumor: recognition of unusual Doppler flow pattern and correlation with computed tomography." Int J Cardiovasc Imaging; 23(4): 507-10.
  20. Jaffery Z, Hudson MP, Jacobsen G, Nowak R and McCord J. (2007) "Modified Thrombolysis in Myocardial Infarction (TIMI) risk score to risk stratify patients in the emergency department with possible acute coronary syndrome." J Thromb Thrombolysis; 24: 137-144.   
  21. Jaffery Z, Kowalski M, Weaver WD and Khanal S. (2007) "A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery." Eur J Cardiothorac Surg; 31(4): 691-697.   
  22. Kanjanauthai S, Ananthasubramaniam K. (2007) "Integral role of cardiovascular magnetic resonance imaging in the diagnostic workup of suspected takotsubo cardiomyopathy; avoiding misdiagnosis."  Cardiol J; 14:1-3.
  23. Kenigsberg DN, Khanal S, Kowalski M and Krishnan SC. (2007) "Prolongation of the QTc interval is seen uniformly during early transmural ischemia." J Am Coll Cardiol; 49(12): 1299-305.
  24. Keteyian SJ. (2007) "Exercise rehabilitation in chronic heart failure." Coron Artery Dis 17(3): 233-7. 
  25. Ketterer MW, Brawner CA, Van Zant M, Keteyian SJ, Ehrman JK, Knysz W, Farha A, Deveshwar S and Wulsin L. (2007) "Empirically derived psychometric screening for emotional distress in coronary artery disease patients: efficiency, efficacy, and source." J Cardiovasc Nurs; 22(4): 320-5. 
  26. Khanal S, Obeidat O, Hudson MP, Al-Mallah M, Bloome M, Lu M, Greenbaum AB, Kugelmass AD and Weaver WD. (2007) "Active Lipid Management In Coronary Artery Disease (ALMICAD) study." Am J Med; 120(8): 734 e11-17.
  27. Lanfear DE, Jones PG, Marsh S, Cresci S, Spertus JA and McLeod HL. (2007) "Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome." Am Heart J; 154(3): 561-6.
  28. Lanfear DE and McLeod HL. (2007) "Pharmacogenetics: using DNA to optimize drug therapy." Am Fam Physician; 76(8): 1179-82.
  29. Lanfear DE, Spertus JA and McLeod HL. (2007) "Beta2-adrenergic receptor genotype predicts survival: implications and future directions." J Cardiovasc Nurs; 21(6): 474-7. 
  30. Lanfear DE, Stolker JM, Marsh S, Rich MW and McLeod HL. (2007) "Genetic variation in the B-Type natiuretic peptide pathway affects BNP levels." Cardiovasc Drugs Ther; 21(1): 55-62.
  31. Maltsev VA, Silverman N, Sabbah HN and Undrovinas AI. (2007) "Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability." Eur J Heart Fail; 9(3): 219-27.
  32. Mann DL, Acker MA, Jessup M, Sabbah HN, Starling RC, Kubo SH. (2007)  "Clinical evaluation of the CorCapTM Cardiac Support Device in patients with dilated cardiomyopathy.  Ann Thorac Surg; 84:1226-1235.
  33. Mehta R, Greenbaum AB, Lokhnygina L, Newby LK, Van de Werf F, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA. (2007) "Timing of death and myocardial infarction in patients with non ST-segment elevation acute coronary syndromes: insights from randomized clinical trials."  J of Interventional Cardiol; 20(5): 299-306.
  34. Rastogi S, Mishra S, Zaca V, Alesh I, Gupta RC, Goldstein S and Sabbah HN. (2007) "Effect of Long-term Monotherapy with the Aldosterone Receptor Blocker Eplerenone on Cytoskeletal Proteins and Matrix Metalloproteinases in Dogs with Heart Failure." Cardiovasc Drugs Ther; 21(6):415-22.
  35. Rastogi S, Mishra S, Zaca V, Mika Y, Rousso B and Sabbah HN. (2007) "Effects of Chronic Therapy with Cardiac Contractility Modulation Electrical Signals on Cytoskeletal Proteins and Matrix Metalloproteinases in Dogs with Heart Failure." Cardiology; 110(4): 230-37.
  36. Sabbah HN, Imai M, Cowart D, Amato A, Carminati P and Gheorghiade M. (2007) "Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure." Am J Cardiol; 99(2A): S41-6. 
  37. Sabbah HN, Imai M, Cowart D, Zhang D, Amato A, Carminati P, Gheorghiade M. (2007) "Hemodynamic properties of a new-generation positive luso-inotropic agent for the treatment of advanced heart failure."  Am J Cardio; l99:41A-46A.
  38. Sharov VG, Todor A, Khanal S, Imai M and Sabbah HN (2007) "Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure." J Mol Cell Cardiol; 42(1): 150-8.
  39. Shin DD, Brandimarte F, DeLuca L, Sabbah HN, Fonarow GC, Filippatos G, Komajda M, Gheorghiade M:. (2007) "Review of Current and Investigational Pharmacologic Agents for Acute Heart Failure Syndromes."  Am J Cardiol; 99:4A-23A. 
  40. Silver B, Greenbaum A, McCarthy S. (2007) "Improvement in sleep apnea associated with closure of a patent foramen ovale."  J Clin Sleep Med; 3(3):295-296.
  41. Sinno MC, Khanal S, Al-Mallah MH, Arida M and Weaver WD. (2007) "The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials." Am Heart J; 153(4): 579-86. 
  42. Starling RC, Jessup M, Oh JK, Sabbah HN, Acker MA, Mann ML, Kubo SH. (2007) "Sustained benefits of the CorCapTM Cardiac Support Device on left ventricular remodeling: 3 year follow up results from the Acorn Clinical Trial."  Ann Thorac Surg; 84:1236-1242.
  43. Stough WG, Zannad F, Pitt B, Goldstein S. (2007) "Globalization of cardiovascular clinical research:  The balance between meeting medical needs and maintaining scientific standards."  Am Heart J; 54:232-238.
  44. Suzuki G, Khanal S, Rastogi S, Morita H, Mishima T, Anagnostopoulos PV, Nass O, Sharov VG, Tanhehco EJ, Goldstein S and Sabbah HN. (2007) "Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure." Cardiovasc Drugs Ther; 21(1): 29-36.
  45. Thompson K, Saab G, Birnie D, Chow BJ, Ukkonen H, Ananthasubramaniam K, Dekemp RA, Garrard L, Ruddy TD, Dasilva JN and Beanlands RS. (2007) "Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy?" J Nucl Med; 47(11): 1763-8.
  46. Tricoci P, Peterson ED, Chen AY, Newby LK, Harrington RA, Greenbaum AB, Cannon CP, Gibson CM, Hoekstra JW, Pollack CV, Ohman EM, Gibler WB, Roe MT. (2007)  "Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention."  Am J Cardiol; 99:1389-1393.
  47. Ward RP, Al-Mallah M, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, McCallister BD, Mehta R, Polk DM, Tilkemeier PL, Vashist A, Williams KA, Wolinsky DG, Ficaro EP. (2007) "American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI)."  J Nucl Cardiol; 14(6):e26-38.
  48. Whellan DJ, O'Connor CM, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Pina IL. (2007) "HF-ACTION Trial Investigators:  Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale."  Am Heart J; 153(2):201-211.
  49. Zaca V, Brewer R, Khanal S, Imai M, Jiang A, Wang M, Goldstein S, Sabbah HN. (2007) "Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with the Acorn Cardiac Support Device: an echocardiographic study."  J Cardiac Failure; 13:312-317.
  50. Zaca V, Rastogi S, Imai M, Wang M, Sharov VG, Jiang A, Goldstein S, Sabbah HN. (2007) "Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure."  J Am Coll Cardiol; 50:551-557.
Endocrinology and Metabolism Top
  1. Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, and Waberski B. (2007) "Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?"  Diabetes Care; 30:2613-2618.
  2. Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K and Simons-Morton DG. (2007) "Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 80i-89i. 
  3. Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC, Jr., Grimm RH, Jr., Margolis KL, Probstfield JL, Simons-Morton DG and Sullivan MD (2007) "Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods." Am J Cardiol; 99(12A): 21i-33i. 
  4. Carter RE, Lackland DT, Cleary PA, Yim E, Lopes-Virella MF, Gilbert GE, and Orchard TJ. (2007)  "Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in Diabetes Control and Complications Trial."  Diabetes Care; 30:2646-2648.
  5. Cushman WC, Grimm RH, Jr., Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A and Basile JN. (2007) "Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 44i-55i. 
  6. Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F and Feeney P. (2007) "Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 34i-43i. 
  7. Ginsberg HN, Bonds DE, Lovato LC, Crouse JR, Elam MB, Linz PE, O'Connor P J, Leiter LA, Weiss D, Lipkin E and Fleg JL. (2007) "Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 56i-67i. 
  8. Goff DC, Jr., Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL and Simons-Morton DG. (2007) "Prevention of Cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 4i-20i. 
  9. Jacobson A, Ryan CM, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Silvers N, Harth J, Musen G, and The DCCT/EDIC Research Study Group. (2007) "Long-term effect of diabetes and its treatment on cognitive function".  The New England Journal of Medicine; 356:34-44.
  10. Kingry C, Bastien A, Booth G, Geraci TS, Kirpach BR, Lovato LC, Margolis KL, Rosenberg Y, Sperl-Hillen JM, Vargo L, Williamson JD and Probstfield JL. (2007) "Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial." Am J Cardiol; 99(12A): 68i-79i. 
  11. Kruger DF. (2007) "Basal-prandial insulin: when is the right time to initiate treatment?" Nurse Pract; 32(5): 24-9; quiz 29-30.
  12. Kruger DF, Aronoff SL and Edelman SV. (2007) "Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis." Diabetes Educ; 33 Suppl 2 32S-46S; quiz 47S-48S. 
  13. Kruger DF. (2007) "The other "insulin resistance": overcoming barriers to insulin use and encouraging diabetes self-management." Diabetes Educ; 33 Suppl 4:80S-81S. 
  14. Kruger DF. (2007) "Tying it all together: matching insulin regimens to individual patient needs." Diabetes Educ; 33 Suppl 4:91S-95S. 
  15. Kruger DF and Kulkarni K. (2007)  "Insulin treatment of patients with diabetes and gain: what do you need to know as a diabetes nurse?"   The Internet Journal of Advanced Nursing Practice; ISSN:1523-6064, Vol 9, No. 1.
  16. Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS, and The DCCT/EDIC Study Research Group.  (2007) "The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study."  Diabetes Care; 30:2107-2112.
  17. Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH and Thomas A. (2007) "Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects." J Am Soc Nephrol; 18(3): 944-51.
  18. Skyler JS, Ponder S, Kruger DF, Matheson D, and Parkin CG.  (2007) "Is there a place for insulin pump therapy in your practice?"  Clinical Diabetes; 25(2): 50-56.
  19. Stys A and Kulkarni K. (2007) "Clinical decision making.  Identification of self-care behaviors and adoption of lifestyle changes result in sustained glucose control and reduction of comorbidities in type 2 diabetes." Diabetes Spectrum; 20(1): 55-8. 
  20. Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Narayan KM, Nwachuku C, O'Connor PJ and Zhang P. (2007) "Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design." Am J Cardiol; 99(12A): 90i-102i. 
  21. Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A and Launer LJ. (2007) "The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods." Am J Cardiol; 99(12A): 112i-22i.
  22. Whitehouse FW. (2007) "Two Minutes with Diabetes." Practical Diabetology; 26:36-37.

 

Gastroenterology Top
  1. Batke M, Zervos M, Robinson-Dunn B, Silverman AL. (2007) "Clostridium difficile is the most common identifiable cause of infectious colitis". Infectious Diseases in Clinical Practice; 15: 149-53.
  2. Khan SF, Sherbondy MA, Ormsby A, Velanovich V. (2007) "Occlusion of metallic biliary stent related to nickel allergy."  Gastrointest Endosc; 66(2):413-4.
  3. McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, Afdhal NH, Jacobson IM, Muir A, Al-Adhami M, Morris ML, Lekstrom-Himes JA, Efler SM, Davis HL. (2007) "A phase 1b, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus." Hepatology; 46:1341-1349.
  4. McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH. (2007) "Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C and liver disease." N Engl J Med; 357:2227-2236.
  5. Russmann S, Lamerato L, Marfatia A, Motsko SP, Pezzullo JC, Olds G, Jones JK. (2007) "Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol."  Am J Gastroenterol; 102(12):2664-6.
  6. Shiffman ML, Suter F, Bacon BR, Nelson D, Harley H, Sola R, Shafran SD, Barange K, Lin A, Soman A, Zeuzem S for the ACCELERATE Investigators Gordon SC. (2007) "Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3." N Engl J Med; 357:124-134.
General Internal Medicine Top
  1. Williams LK, Joseph CL, Peterson EL, Moon C, Xi H, Krajenta R, Johnson R, Wells K, Booza JC, Tunceli K, Lafata JE, Johnson CC, Ownby DR, Enberg R, Pladevall M. (2007) "Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids".  J Allergy Clin Immunol; 119:168-75.
  2. Williams LK,Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, Lanfear DE, Tunceli K and Pladevall M. (2007) "Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence." J Allergy Clin Immunol; 120(5): 1153-9.
Hematology, Medical Oncology, Josephine Ford Cancer Center Top
  1. Dabak V, Kuriakose P and Raman S. (2007) "Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange." J Clin Apher; 22(6): 330-32.
  2. Hanbali A, Al-Khasawneh K, Johnson CC, Divine G, Ali H. (2007) "Protective effect of diabetes against metastasis in patients with non-small cell lung cancer."  Arch Intern Med; 167:513.
  3. Hanbali A, Wollner I, Neme K and Ulreich C. (2007) "Fatal hypersensitivity reaction to gemtuzumab ozogamicin associated with platelet transfusion." Am J Health Syst Pharm; 64(13): 1401-2. 
  4. Johnson TA, Tenney K, Cichewicz RH, Morinaka BI, White KN, Amagata T, Subramanian B, Media J, Mooberry SL, Valeriote FA and Crews P. (2007) "Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties." J Med Chem; 50(16): 3795-803. 
  5. Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, Menon M, Dou QP and Reddy GP. (2007) "Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer." Cancer Res; 67(16): 7782-8.
  6. Lambing A. (2007) "Bleeding disorders: patient history key to diagnosis." Nurse Pract; 32(12): 16-24.
  7. Robinson SJ, Tenney K, Yee DF, Martinez L, Media JE, Valeriote FA, Soest RW and Crews P. (2007) "Probing the bioactive constituents from chemotypes of the sponge psammocinia aff. bulbosa." J Nat Prod; 70(6): 1002-09. 
  8. Ulcickas Yood M, Quesenberry CP, Jr., Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U and Manos MM. (2007) "Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection." Hepatology; 46(1): 107-12.
Hypertension and Vascular Research Top
  1. Ardanaz N, Beierwaltes WH and Pagano PJ. (2007) "Comparison of H(2)O(2)-induced vasoconstriction in the abdominal aorta and mesenteric artery of the mouse." Vascul Pharmacol; 47(5-6): 288-94.
  2. Cavasin MA, Liao TD, Yang XP, Yang JJ and Carretero OA. (2007) "Decreased endogenous levels of Ac-SDKP promote organ fibrosis." Hypertension; 50(1): 130-6.
  3. Haurani MJ and Pagano PJ. (2007) "Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?" Cardiovasc Res; 75(4): 679-89. 
  4. Haurani MJ, Rubinfeld I, Rao S, Beaubien J, Musial JL, Parker A, Reickert C, Raafat A and Shepard A. (2007) "Are the communication and professionalism competencies the new critical values in a resident's global evaluation process?" J Surg Educ; 64(6): 351-6.
  5. Herrera M and Garvin JL (2007) "Novel role of AQP-1 in NO-dependent vasorelaxation." Am J Physiol Renal Physiol; 292(3): F993-8.
  6. Herrera M and Garvin JL. (2007) "Novel role of AQP-1 in NO-dependent vasorelaxation." Am J Physiol Renal Physiol; 292(5): F1443-51. 
  7. Hong NJ and Garvin JL. (2007) "Flow increases superoxide production by NADPH oxidase via activation of Na-K-2Cl cotransport and mechanical stress in thick ascending limbs." Am J Physiol Renal Physiol; 292(3): F993-8. 
  8. Kim YH, Pech V, Spencer KB, Beierwaltes WH, Everett LA, Green ED, Shin W, Verlander JW, Sutliff RL, and Wall SM. (2007) "Reduced ENaC protein expression contributes to the lower blood pressure observed in Slc26a4 null mice." Am J Physiol Renal Physiol; 293(4): F1314-24.
  9. Li XC and Zhuo JL. (2007) "Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise." Clin Sci (Lond); 113(4): 183-93.
  10. Li XC and Zhuo JL. (2007) "Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells." Am J Physiol Cell Physiol; 293(1): C367-78.
  11. Li XC, Navar LG, Shao Y and Zhuo JL. (2007) "Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice." Am J Physiol Renal Physiol; 293(2): F586-93.
  12. Liu R, Garvin JL, Ren Y, Pagano PJ and Carretero OA. (2007) "Depolarization of the macula densa induces superoxide production via NAD(P)H oxidase." Am J Physiol Renal Physiol; 292(6): F1867-72. 
  13. Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P and Beierwaltes WH. (2007) "Expression and function of the calcium-sensing receptor in juxtaglomerular cells." Hypertension; 50(4): 737-43.
  14. Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P and Beierwaltes WH. (2007) "Decreased intracellular calcium stimulates cAMP and renin release." Hypertension; 49(1): 162-169.
  15. Pagano PJ and Gutterman DD. (2007) "The adventitia: The outs and ins of vascular disease." Cardiovasc Res; 75(4): 636-9.
  16. Peng H, Carretero OA, Liao TD, Peterson EL and Rhaleb NE. (2007) "Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension." Hypertension; 49(3): 695-703. 
  17. Perez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, de Cingolani GC, Yang XP and Cingolani HE. (2007) "Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction." Hypertension; 49(5): 1095-1103. 
  18. Pokharel S and Sharma UC (2007) "Ionotropic stress and integrin. Another link to myocardial remodeling." Hypertension;  49(4): 767-768.   
  19. Ren Y, Garvin JL, Liu R and Carretero OA. (2007) "Possible mechanism of efferent arteriole (Ef-Art) tubuloglomerular feedback." Kidney Int; 71(9): 861-6. 
  20. Ren Y, Garvin JL, Liu R and Carretero OA. (2007) "Crosstalk between the connecting tubule and the afferent arteriole regulates renal microcirculation." Kidney Int; 71(11): 1116-21. 
  21. Riad A, Zhuo JL, Schultheiss HP and Tschope C. (2007) "The role of the renal kallikrein-kinin system in diabetic nephropathy." Curr Opin Nephrol Hypertens; 16(1): 22-6. 
  22. Wang F, Keimig T, He Q, Ding J, Zhang Z, Pourabdollah-Nejad S and Yang XP. (2007) "Augmented healing process in female mice with acute myocardial infarction." Gend Med; 4(3): 230-47.
  23. Xu J, Carretero OA, Lin CX, Cavasin MA, Shesely EG, Yang JJ, Reudelhuber TL and Yang XP. (2007) "Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction." Am J Physiol Heart Circ Physiol; 293(3): H1900-7.
  24. Zhuo JL, Carretero OA, Peng H, Li XC, Regoli D, Neugebauer W and Rhaleb NE. (2007) "Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts." Am J Physiol Heart Circ Physiol; 292(2): H984-93.
  25. Zhuo JL and Li XC. (2007) "Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells." J Renin Angiotensin Aldosterone Syst; 8(1): 23-33.
Infectious Diseases Top
  1. Batke M, Zervos M, Robinson-Dunn B, Silverman A. (2007) "Clostridium difficile is the most common cause of infectious colitis."  Infect Dis Clin Pract; 15:49-53. 
  2. Brar I, Shuter J, Thomas A, Daniels E and Absalon J. (2007) "A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort." J Acquir Immune Defic Syndr; 45(1): 66-71. 
  3. Chen AY, Zervos MJ and Vazquez JA. (2007) "Dalbavancin: a novel antimicrobial." Int J Clin Pract; 61(5): 853-63. 
  4. Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK and Zervos MJ. (2007) "Epidemiology and outcomes of community-associated methicillin-resistant staphylococcus aureus infection." J Clin Microbiol; 45(6):1705-11. 
  5. Davis SL, Vazquez JA and McKinnon PS. (2007) "Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients." Ann Pharmacother; 41(4): 568-73. 
  6. Haque NZ, Davis SL, Manierski CL, Vager D, Donabedian SM, Perri MB, Sabbagh R, Cheema F and Zervos MJ. (2007) "Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA)." Int J Antimicrob Agents; 30(1): 72-7. 
  7. Katramados, AM, Sripathi N, Brar I, Mitsias PD.  (2007) "Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient."  AIDS; 21(6):778-780.
  8. Markowitz NPM, Rosenblum M. (2007) "Neurological manifestations of the acquired immunodeficiency syndrome." Commentary.  J Neurosurg; 207:1251-52.
  9. Pappas PG, Rotstein MFC, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez J, Dupont BF, Horn D L, Ostrodky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.  (2007) "Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis."  Clin Infect Dis; 45:883-93. 
  10. Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts, R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ, Vazquez J for the Anidulafungin Study Group.  (2007) "Anidulafungin versus fluconazole for invasive candidiasis."  N Eng J Med; 356:2472-2482.
  11. Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher A, Heitman J, Wagener MM, Husain S, and the Cryptococcal Collaborative Transplant Study Group.  (2007) "Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality."  J Infect Dis; 195(5):756-64.
  12. Skiest DJ, Vazquez JA, Anestead GM, Graybill JR, Reynes J, Ward D, Hare R, Boparai N, Isaacs R.  (2007) "Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection."  Clin Infect Dis 44(4):607-14.
  13. Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL; Legionella Study Group.  (2007) "Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations."  Infect Control Hosp Epidemiol; 28:818-24.
  14. Vazquez JA, Skiest DJ, Tissot-Dupont H, Lennox JL, Boparai N, and Isaacs R.  (2007) "Safety and efficacy of Posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection." HIV Clin Trials; 8(2): 86-97.
  15. Vazquez JA. (2007) "Combination antifungal therapy: the new frontier." Future Microbiol; 2(115-39).
  16. Vazquez JA. (2007) "Posaconazole for the management of mucosal candidiasis." Future Microbiol; 2(245-56).
  17. Vazquez JA.  (2007) "Role of posaconazole in the treatment of oropharyngeal and esophageal candidiasis."  Therap Clin Risk Mgmt; 3(4):533-542.
  18. Vazquez JA.  (2007) "Diagnosing and managing oropharyngeal candidiasis."  Infect Med; 24:427-436.
  19. Vazquez JA.  (2007) "Echinocandin therapy for invasive fungal infections caused by candida."  Commentary.  July; Infect Dis Forum Rpt.
  20. Vigil KJ, Pasumarthy A, Johnson LB, Sheppard T, El-Ghoroury M, and del Busto R. (2007).  "Nocardiosis in renal transplant patients: role of current immunosuppressant agents."  Infect Dis Clin Pract; 15:171-173.
  21. Zervos M, Martinez FJ, Amsden GW, Rothermel CD and Treadway G. (2007) "Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis." Int J Antimicrob Agents; 29(1): 56-61.
Book Chapters
  1. Chen A, Chow J, Muder R, Zervos M.  The Enterococcus.  In: Antimicrobial Therapy and Vaccines (V. Yu, R. Weber, D. Raoult, Eds.), Apple Tree Publications, New York, NY, 2007.
  2. Oprea SF and Zervos MJ.  Enterococcus and its Association with Foodborne Illness.  In: Foodborne Diseases (S. Simjee, Ed.), Humana Press, Totowa, NJ, 2007.
Nephrology Top
  1. Arif A, Ravani P , Roy-Chaudhury P, Spergel LM, Besarab A. (2007) "The native arterio-venous fistula in 2007: vascular mapping techniques: advantages and disadvantages."  J Nephrol; 20:299-303.
  2. Arif A, Ravani P, Roy-Chaudhury P, Spergel LM, Besarab A. (2007) "The native arterio-venous fistula in 2007: Interventional nephrology:From episodic to coordinated vascular access care."  J Nephrol; 20:399-405.
  3. Baccora MH, Cortes P, Hassett C, Taube DW and Yee J. (2007) "Effects of long-term elevated glucose on collagen formation by mesangial cells." Kidney Int 72(10): 1216-25.
  4. Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC and Beyer U. (2007) "Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease." Clin Ther; 29(4): 626-39. 
  5. Besarab A, Ravani P, Spergel LM, Roy-Chaudhury P and Asif A. (2007) "The native arteriovenous fistula in 2007. Research needs." J Nephrol; 20(6): 668-73.
  6. Besarab A, Asif A, Roy-Chaudhury P, Spergel LM and Ravani P. (2007) "The native arteriovenous fistula in 2007. Surveillance and monitoring." J Nephrol; 20(6): 656-67.
  7. Duronio A, Bajjoka I, Hsaiky L, Parasuraman R. (2007) "Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients." Ann Pharmacotherap; 41(2):354-8.
  8. Fishbane S, Besarab A. (2007) "On the mechanisms of increased mortality risk with erythropoietin treatment to higher hemoglobin targets." Clin J Am Soc Nephrol; 9:2(6):1274-82.
  9. Giannico G, Cortes P, Baccora MH, Hassett C, Taube DW, Yee J. (2007) "Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells."  Am J Physiol - Renal Physiology; Jan 292(1):F57-65.
  10. Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J. (2007) "Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis."  Diabetic Medicine; May 24(5):486-93.
  11. Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U, on behalf of the AMICUS study Investigators. (2007) "Efficacy of intravenous polyethylene-glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial." Am J Kidney Dis; 50:989-1000.
  12. Provenzano R,  Besarab A, Macdougall IC, Ellison DH, Maxwell PA, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC on behalf of the BA16528 Study Investigators. (2007) "The Continuous Erythropoietin Receptor Activator (C.E.R.A.) corrects anemia at extended administration intervals in Patients with chronic kidney disease not on dialysis. Results of a phase 2 study."  Clin Nephrol; 67:306-307.
  13. Ravani P, Spergel LM, Roy-Chaudhury P, Arif A, Besarab A. (2007) "Clinical epidemiology of AVF and Grafts in 2007."  J Nephrol; 22:20:141-149.
  14. Reed J, Charytan C, Yee J. (2007) "The safety of intravenous iron sucrose use in the elderly patient."  Consultant Pharmacist; Mar 22(3):230-8.
  15. Roy-Chaudhury P, Spergel LM, Besarab A, Arif A,  Ravani P. (2007) "Biology of arteriovenous fistula failure."  J Nephrol; 20:150-163.
  16. Shafi ST and Gupta M. (2007) "Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis." J Vasc Access; 8(2): 103-8. 
  17. Spergel LM, Ravani P, Roy-Chaudhury P, Arif A, Besarab A. (2007) "The native arterio-venous fistula in 2007:  Surgical salvage of the autogenous arterio-venous fistula (AVF)."  J Nephrol; 20:386-398.
  18. Spergel LM, Ravani P, Roy-Chaudhury P, Arif A, Besarab A. (2007) "The native arterio-venous fistula in 2007: Autogenous arteriovenous fistula options."  J Nephrol 20:288-298.
Book Chapters
  1. Besarab A and Ayyoub F. Anemia in Renal Disease.  In: Diseases of the Kidney, 8th Ed. (Eds. Schrier, R.) Lippincott, Williams, & Wilkins Philadelphia 2007;pp 2405-2430.
  2. Kumar V, Depner T, Besarab A, Ananthakrishnan. Arteriovenous Access for Hemodialysis. In: Handbook of Dialysis, 3rd edition, (Eds: Daurgirdas JT, Blake PG, Ing TS.) Lippincott, Williams & Wilkins, Philadelphia, PA, 2007 Chapter 7 pp 105-126.
Pulmonary and Critical Care Medicine Top
  1. Kaza V, Bandi V, Guntupalli KK. (2007) "Acute severe asthma: recent advances." Curr Opin Pulm Med; Jan;13(1):1-7.
  2. Kaza V, Kats MF, Cumming S, Frost AE, Safdar Z. (2007) "Correlation of chest radiograph pattern with genotype, age and gender in adult cystic fibrosis. A single-center study." Chest; Aug;132(2):569-74.
  3. Kvale PA, Selecky PA and Prakash UB. (2007) "Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)." Chest; 132(3 Suppl): 368S-403S.
  4. Mayse M, Laviolette M, Rubin A, Lampron N, Simoff M, Duhamel D, Musani A, Yung R, Mehta A. (2007) "Clinical pearls of bronchial thermoplasty." JOB; 14:115-123.
  5. Pinsky P, Freedman M, Oken M, Kvale P, Caporaso N, Gohagan J. (2007) "Prevalence of non-cancer-related abnormalities on low-dose spiral computed tomography versus chest radiograph in a screening population."  Thorax; 62:190-191.
  6. Stein PD, Woodard PK, Weg JG, Wakefield TW, Tapson VF, Sostman HD, Sos TA, Quinn DA, Leeper KV Jr, Hull RD, Hales CA, Gottschalk A, Goodman LR, Fowler SE, Buckley JD; PIOPED II Investigators. (2007) "Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators." Radiology; Jan;242(1):15-21.
  7. Stein PD, Beemath A, Matta F, Weg J, Yusen R, Hales C, Hull R, Leeper K, Sostman D, Tapson V, Buckley JD, Gottschalk A, Goodman L, Wakefield Woodward P. (2007) "Clinical characteristics of patients with acute pulmonary embolism: Data from PIOPED II." Am J Med; 120(10):871-79.
  8. Snow WM, Connett JE, Sharma S, Murray, RB. (2007) "Predictors of attendance and dropout at the Lung Health Study 11 year follow up."  Contemporary Clinical Trials 28; 25-32.
  9. Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE. (2007) "Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial."  Hum Genet; 122(1):41-9.
Sleep Disorders and Research Center Top
  1. Budhiraja R, Parthasarathy S, Drake C, Roth T, Sharief I, Budhiraja P, Saunders V, and Hudgel D. (2007) "Early CPAP use identifies subsequent adherence to CPAP therapy."  Sleep; 30(3): 320-324.
  2. Drake CL. (2007) "Managing chronic insomnia in the psychiatric patient." Psychiatric Times; April 26: 1-4. 
  3. Freedman RR and Roehrs TA. (2007) "Sleep disturbance in menopause." Menopause; 14(5): 826-9.
  4. Kryger M, Wang-Weigand S, and Roth T. (2007) "Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea."  Sleep & Breathing; 11(3): 159-164.
  5. Krystal A, Fava M, Rubens R, Wessel T, Caron J, Wilson P, Roth T and McCall W. (2007) "Evaluation of eszopiclone discontinuation after coptherapy with fluoxetine for insomnia with coexisting depression."  Journal of Clinical Sleep Medicine; 3(1): 48-55.
  6. Perez-Chada D, Perez-Lloret S, Videla AJ, Cardinali D, Bergna MA, Fernandez-Acquier M, Larrateguy L, Zabert GE, and Drake CL. (2007) "Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers: A study using the pediatric daytime sleepiness scale." Sleep; 30(12): 1698-1703.
  7. Rohsenow DJ, Howland J, Minsky SJ, Greece J, Almeida A, and Roehrs TA.  (2007) "The acute hangover scale: a new measure of immediate hangover systems."  Addictive Behaviors; 32:1314-1320.
  8. Roth T. (2007)  "Introduction: understanding neuronal pathways: novel targets for the management of insomnia."  The Journal of Clinical Psychiatry; 68(5 suppl): 4-5.
  9. Roth T. (2007) "A physiologic basics for the evolution of pharmacologic therapies for insomnia."  The Journal of Clinical Psychiatry; 68(5 suppl): 13-18.
  10. Roth T. (2007) "The nature of insomnia.  Long-term issues in the treatment of sleep disorders."  CNS Spectrums; 12(7 suppl 10): 1-16.
  11. Roth T. (2007)  "Introduction - Sleep therapy: new generation pharmacologic agents for managing insomnia." Journal of Clinical Sleep Medicine; 3(5).
  12. Roth T. (2007) "Insomnia: definition, prevalence, etiology and consequences."  Journal of Clinical Sleep Medicine; 3(5 Suppl): S7-10.
  13. Roth T, Roehrs T, and Pies R. (2007) "Insomnia: pathophysiology and implications for treatment."  Sleep Medicine Reviews; 11(1): 71-79.
  14. Roth T, Seiden D, Wang-Weigand S, and Zhang J. (2007) "A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia."  Current Medical Research and Opinions; 23(5): 1005-1014.
  15. Roth T, Roehrs T and Pies R. (2007) "Insomnia: pathophysiology and implications for treatment." Sleep Med Rev; 11(1): 71-9.
  16. Roth T, Seiden D, Wang-Weigand S and Zhang J. (2007) "A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia." Curr Med Res Opin; 23(5): 1005-14. 
  17. Roth T. (2007) "A physiologic basis for the evolution of pharmacotherapy for insomnia." J Clin Psychiatry; 68 Suppl 5(13-8). 
  18. Roth T. (2007) "Understanding neuronal pathways: novel targets for the management of insomnia." J Clin Psychiatry; 68 Suppl 5(4-5). 
  19. Roth T. (2007) "Insomnia: definition, prevalence, etiology, and consequences." J Clin Sleep Med; 3(5 Suppl): S7-10.
  20. Roth T. (2007) "Introduction - Advances in our understanding of insomnia and its management." Sleep Med; 8 Suppl 3(25-6).
  21. Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, Seiden D and Lankford A. (2007) "Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia." Sleep; 30(11): 1555-61.
  22. Roth T, Schwartz JR, Hirshkowitz M, Erman MK, Dayno JM and Arora S (2007) "Evaluation of the safety of modafinil for treatment of excessive sleepiness." J Clin Sleep Med; 3(6): 595-602.
  23. Roth T (2007) "Introduction: narcolepsy and excessive daytime sleepiness: from the bench to the bedside." J Clin Psychiatry; 68 Suppl 13:4.
  24. Roth T. (2007) "Narcolepsy: treatment issues." J Clin Psychiatry; 68 Suppl 13:16-9.
  25. Roth T, Krystal AD and Lieberman JA, 3rd. (2007) "Long-term issues in the treatment of sleep disorders." CNS Spectr; 12(7 Suppl 10): 1-13.
  26. Villareal A, Hudgel D and Roth T. (2007) "Improvement of obstructive sleep apnea after radiation therapy of vocal cord carcinoma." Sleep Med; 9(1):96-7.
  27. Walsh JK, Krystal AD, Amato DA, Ruben R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, and Roth T. (2007) "Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life and work limitations."  Sleep; 30(8): 959-968.
  28. Walsh JK, Moscovitch A, Burke J, Farber R, and Roth T. (2007) "Efficacy and tolerability of indiplon in older adults with primary insomnia."  Sleep Medicine; 8(7-8):  753-759.
  29. Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, and Roth T. (2007) "Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia."  Journal of Clinical Sleep Medicine; 3(5): 495-504.
Book Chapters
  1. Richardson, GS. Shift work sleep disorder. Pp.71-80. In: Sleep Disorders: A Brief Guide. (T. L. Lee-Chiong, Ed.), John Wiley & Sons, Hoboken, NJ, 2007.